The US Food and Drug Administration has approved Pfizer’s Retacrit, a biosimilar of Amgen's Epogen and Johnson & Johnson's Procrit. The US Food and Drug Administration has approved Pfizer’s Retacrit, ...
Johnson & Johnson's anaemia treatment Procrit (epoetin alfa) is more effective at boosting red blood cells in patients undergoing cancer chemotherapy than rival drug Aranesp (darbepoetin alfa) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results